{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF12252",
      "entity_text" : "side",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P05362",
      "entity_text" : "ICAM-1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In the future, I-domain will be conjugated to drug molecules to direct the drugs to cells with overexpressing ICAM-1 for lowering the drug side effects XREF_BIBR - XREF_BIBR.",
  "reading_complete" : "2020-08-02T09:49:05Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T09:48:06Z",
  "trigger" : "lowering",
  "evidence" : [ "ICAM-1 for lowering the drug side" ],
  "pmc_id" : "3100608",
  "score" : 0
}